Regulation of testicular function in men: implications for male hormonal contraceptive development

被引:40
作者
Amory, JK [1 ]
Bremner, WJ [1 ]
机构
[1] Univ Washington, Populat Ctr Res Reprod, Dept Med, Seattle, WA 98195 USA
关键词
spermatogenesis; testosterone; FSH; LH; contraception; male;
D O I
10.1016/S0960-0760(03)00205-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the adult male, the testes produce both sperm and testosterone. The function of the testicles is directed by the central nervous system and pituitary gland. Precise regulation of testicular function is conferred by an elegant feedback loop in which the secretion of pituitary gonadotropins is stimulated by gonadotropin hormone-releasing hormone (GnRH) from the hypothalamus and modulated by testicular hormones. Testosterone and its metabolites estradiol and dihydrotestosterone (DHT) as well as inhibin B inhibit the secretion of the gonadotropins both directly at the pituitary and centrally at the level of the hypothalamus. In the testes, LH stimulates testosterone synthesis and FSH promotes spermatogenesis, but the exact details of gonadotropin action are incompletely understood. A primary goal of research into understanding the hormonal regulation of testicular function is the development of reversible, safe and effective male hormonal contraceptives. The administration of exogenous testosterone suppresses pituitary gonadotropins and hence spermatogenesis in most, but not all, men. The addition of a second agent such as a progestin or a GnRH antagonist yields more complete gonadotropin suppression; such combination regimens effectively suppress spermatogenesis in almost all men and may soon bring the promise of hormonal male contraception to fruition. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:357 / 361
页数:5
相关论文
共 57 条
[1]  
Amory JK, 2001, J ANDROL, V22, P1053
[2]   Desogestrel plus testosterone effectively suppresses spermatogenesis but also causes modest weight gain and high-density lipoprotein suppression [J].
Anawalt, BD ;
Herbst, KL ;
Matsumoto, AM ;
Mulders, TMT ;
Coelingh-Bennink, HJT ;
Bremner, WJ .
FERTILITY AND STERILITY, 2000, 74 (04) :707-714
[3]  
Anawalt BD, 1999, J ANDROL, V20, P407
[4]   Serum inhibin B levels reflect sertoli cell function in normal men and men with testicular dysfunction [J].
Anawalt, BD ;
Bebb, RA ;
Matsumoto, AM ;
Groome, NP ;
Illingworth, PJ ;
McNeilly, AS ;
Bremner, WJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (09) :3341-3345
[5]   Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study .3. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterones [J].
Anderson, RA ;
Wallace, AM ;
Wu, FCW .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (03) :902-908
[6]   Suppression of spermatogenesis by etonogestrel implants with depot testosterone: Potential for long-acting male contraception [J].
Anderson, RA ;
Kinniburgh, D ;
Baird, DT .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (08) :3640-3649
[7]   COMPARISON OF A GONADOTROPIN-RELEASING-HORMONE ANTAGONIST PLUS TESTOSTERONE (T) VERSUS-T ALONE AS POTENTIAL MALE CONTRACEPTIVE REGIMENS [J].
BAGATELL, CJ ;
MATSUMOTO, AM ;
CHRISTENSEN, RB ;
RIVIER, JE ;
BREMNER, WJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (02) :427-432
[8]  
BAGATELL CJ, 1994, J ANDROL, V15, P15
[9]   Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: A promising male contraceptive approach [J].
Bebb, RA ;
Anawalt, BD ;
Christensen, RB ;
Paulsen, CA ;
Bremner, WJ ;
Matsumoto, AM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (02) :757-762
[10]   Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism:: phase I studies [J].
Behre, HM ;
Abshagen, K ;
Oettel, M ;
Hübler, D ;
Nieschlag, E .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1999, 140 (05) :414-419